14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of VSTM
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Verastem stock upgraded from Strong Sell Candidate to Sell Candidate after Wednesday trading session.
(Updated on Apr 24, 2024)

Sell candidate since Apr 18, 2024 Loss -8.99% PDF

The Verastem stock price fell by -3.12% on the last day (Wednesday, 24th Apr 2024) from $9.61 to $9.31. It has now fallen 9 days in a row. During the last trading day the stock fluctuated 5.18% from a day low at $9.27 to a day high of $9.75. The price has fallen in 9 of the last 10 days and is down by -17.61% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -23 thousand shares and in total, 79 thousand shares were bought and sold for approximately $731.98 thousand.

The stock has broken the very wide and falling short-term trend down. Firstly a stronger fallrate is indicated, but false breaks and "sell-off" may occur. However, a further fall is realistic and any reactions back to the breaking point ($9.54) are considered to be a "second chance" to get out. According to the fan-theory $6.86 will represent the new bottom line of the next trend, but it is far too early to say this for certain.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

VSTM Signals & Forecast

There are few to no technical positive signals at the moment. The Verastem stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $10.07 and $11.22. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, March 22, 2024, and so far it has fallen -22.67%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Verastem stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.480 between high and low, or 5.18%. For the last week the stock has had daily average volatility of 5.72%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (VSTM) For The Upcoming Trading Day Of Thursday 25th

For the upcoming trading day on Thursday, 25th we expect Verastem to open at $9.44, and during the day (based on 14 day Average True Range), to move between $8.67 and $9.95, which gives a possible trading interval of +/-$0.635 (+/-6.83%) up or down from last closing price. If Verastem takes out the full calculated possible swing range there will be an estimated 13.65% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $10.84, some $1.53 (16.43%) from the current price of $9.31, our system finds the risk reward not very attractive.

Is Verastem stock A Buy?

Verastem holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -4.529 Sell Candidate Upgraded

Predicted Opening Price for Verastem of Thursday, April 25, 2024

Fair opening price April 25, 2024 Current price
$9.44 ( 1.43%) $9.31

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for VSTM

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 9.92 6.59 %
R2 9.74 4.62 %
R1 9.63 3.40 %
Current price: 9.31
Support S1 9.26 -0.537 %
S2 9.15 -1.75 %
S3 8.96 -3.72 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 11.31 21.48 %
R2 11.00 18.15 %
R1 10.84 16.43 %
Current price 9.31
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for Verastem Stock and on which exchange is it traded?
The symbol for Verastem is VSTM and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Verastem Stock?
Verastem holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

How to buy Verastem Stock?
Verastem Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Verastem Stock.

What's the current price of Verastem Stock?
As of the end of day on the Apr 24, 2024, the price of an Verastem (VSTM) share was $9.31.

What is the 52-week high and low for Verastem Stock?
The 52-week high for Verastem Stock is $15.18 and the 52-week low is $4.26.

What is the market capitalization of Verastem Stock?
As of the Apr 24, 2024, the market capitalization of Verastem is 235.501M.

When is the next earnings date for Verastem?
The upcoming earnings date for Verastem is May 14, 2024.
Click to get the best stock tips daily for free!

About Verastem

Verastem Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylate MEK. The company also engages in developing RAMP 201, an adaptive two-part multicenter, parallel coho... VSTM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT